Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,263 | -7,179 | -3,747 | -1,582 | -6,588 |
| Depreciation Amortization | 573 | 420 | 274 | 134 | 584 |
| Accounts receivable | -249 | -176 | 175 | 168 | -99 |
| Other Working Capital | 3,242 | 1,958 | 780 | -69 | 39 |
| Other Operating Activity | 640 | 253 | -109 | -113 | 277 |
| Operating Cash Flow | $-7,057 | $-4,724 | $-2,627 | $-1,463 | $-5,788 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -102 | -81 | -44 | -3 | -60 |
| Purchase Sale Intangibles | -337 | -285 | -191 | -121 | -281 |
| Other Investing Activity | -337 | -285 | -191 | -121 | -281 |
| Investing Cash Flow | $-439 | $-366 | $-234 | $-125 | $-340 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -21 |
| Common Stock Issued | 1,607 | 1,539 | 1,480 | 1,256 | N/A |
| Dividend Paid | -276 | -157 | N/A | N/A | N/A |
| Other Financing Activity | 10,339 | 9,731 | 9,731 | 0 | 15,694 |
| Financing Cash Flow | $11,669 | $11,113 | $11,211 | $1,256 | $15,674 |
| Beginning Cash Position | 13,461 | 13,461 | 13,461 | 13,461 | 875 |
| End Cash Position | 17,890 | 19,740 | 22,068 | 13,129 | 13,461 |
| Net Cash Flow | $4,429 | $6,280 | $8,607 | $-332 | $12,585 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,057 | -4,724 | -2,627 | -1,463 | -5,788 |
| Capital Expenditure | -102 | -81 | -44 | -3 | -60 |
| Free Cash Flow | -7,160 | -4,804 | -2,670 | -1,466 | -5,847 |